Insmed (INSM) Misses Q4 EPS by 37c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $126.29 -0.31%
Revenue Growth %: +253.1%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +253.1%
Financial Fact:
Total operating expenses: 37.15M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q4 EPS of ($1.54), $0.37 worse than the analyst estimate of ($1.17). Revenue for the quarter came in at $263.8 million versus the consensus estimate of $208.2 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Alpha Compute reports $1.57M monthly cash flow and $1.5B pipeline
- HII targets 15% shipbuilding throughput increase for U.S. Navy in 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
